Amgen shifts gears in the weight loss drug market to focus on injectable obesity treatment despite ditching an oral weight loss pill
Amgen shifts gears in the weight loss drug market to focus on injectable obesity treatment despite ditching an oral weight loss pill

Carrot or Stick Approach?

Eh what's up doc? Looks like Amgen is giving a carrot or stick approach to the weight loss market by ditching the oral pill in favor of injectable treatments like MariTide. Gotta say they're really hopping to it!

Weight A Minute There's More

Amgen's decision to focus on injectables has caused quite a stir. The company is looking to join the weight loss drug party but with a twist! And speaking of twists I prefer mine with twisty carrots. Nyah what's up doc?

Ain't I a Stinker?

Investors are all ears as Amgen plays coy with its weight loss treatments. With other drugs in the pipeline and a different take on injectables Amgen is trying to be the king of the carrot patch. For me I'll stick to my carrots thank you very much!

Numbers Don't Lie Doc

Amgen's first quarter earnings are looking pretty swell. They've managed to thump Wall Street's expectations like I thump Elmer Fudd. Looks like Amgen isn't just b b beating around the bush!

That's All Folks!

With Amgen shaking up the weight loss market it's clear they're not bunnying around! Whether it's injectables or oral pills the competition better watch out because Amgen is ready to take a bite out of the weight loss market. What's up doc? Looks like it's game on!


Comments

  • No comments yet. Become a member to post your comments.